Zobrazeno 1 - 10
of 28
pro vyhledávání: '"V, Chylak"'
Autor:
Lesley A. Stewart, S. B. Kaye, S. Pecorelli, N. Colombo, C. Mangioni, R. V. Smalley, B. Y. Yeap, D. W. Wilbur, R. C. Leonard, M. F. Brady, E. Wiltshaw, P. F. Conte, S. Marsoni, J. F.G. Sturgeon, M. H.N. Tattersall, C. Gennatas, C. Trope, A. Athanazziou, D. Guthrie, D. Crowther, D. R. Bell, A. H. Laing, M. Gore, J. B. Vermorken, C. Lewis, E. Gilbey, Giorgio Bolis, H. Bruckner, P. Adnitt, M. K.B. Parmar, M. Tomirotti, H. Meerpohl, H. S. Brodovsky, W. Sauerbrei, J. Pater, R. Canetta, W.W. ten Bokkel Huinink, D. V. Skarlos, H. J. Solomon, M. J. Webb, J. T. Wharton, F. Landoni, P. Y. Liu, M. M. Turbow, J. H. Edmonson, D. S. Alberts, C. J. Cohen, K. Aabo, W. Torri, V. Barley, M. Adams, M. Buyse, C. J. Williams, M. Presti, V. Chylak, U. Bianchi, G. A. Omura
Publikováno v:
Scopus-Elsevier
The purpose of this systematic study was to provide an up to date and reliable quantitative summary of the relative benefits of various types of chemotherapy (non-platinum vs platinum, single-agent vs combination and carboplatin vs cisplatin) in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2151ac8be4c1ee28ab74e9cc655baa87
https://doi.org/10.1038/bjc.1998.710
https://doi.org/10.1038/bjc.1998.710
Publikováno v:
Jugoslavenska ginekologija i perinatologija. 30(3-4)
A retrospective analysis dealt with 28 cases of uterine sarcoma treated in a ten-year period (1975-1984). The most common histological type was leiomyosarcoma. Thirteen patients underwent surgery alone, a combination of surgery and irradiation was pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb6c244c5afb352e3e66f6078650ef0c
https://pubmed.ncbi.nlm.nih.gov/2273905
https://pubmed.ncbi.nlm.nih.gov/2273905
Autor:
Sándor Eckhardt, János Szántó, O. Cerar, V. Chylak, Z. Hernádi, I. Hindy, S. József, É. Juhos, K. Kolaric, J. Kopecny, I. Koza, Z. Mechl, K. Miksics, L. Németh, M. Pawlicki, S. Plesnicar, E. Ploch, Z. Schoket, Z. Stepanek, L. Svancarová, T. Vizhányó, B. Zuchovska
Publikováno v:
Oncology. 44:69-72
The therapeutic efficacy of the combination of cyclophosphamide + epirubicin + cisplatin was evaluated in 107 previously treated or untreated patients with advanced ovarian cancer. The overall response rate was 58.8%, complete remission 36.4% (mean d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51f1a4f30353af4888f8b712de78317a
https://doi.org/10.1159/000226447
https://doi.org/10.1159/000226447
Publikováno v:
Jugoslavenska ginekologija i opstetricija. 23(3-4)
The authors describe the rare case of a triple primary malignant tumor in 59 old women. It consisted of squamous cell carcinoma of the cervix uteri, leiomyosarcoma of myometrium and granulocellular carcinoma of the ovary. The patient was treated by s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e6d8c596478f40d97ceec94b695e302d
https://pubmed.ncbi.nlm.nih.gov/6664108
https://pubmed.ncbi.nlm.nih.gov/6664108
Publikováno v:
Jugoslavenska ginekologija i perinatologija. 28(1-2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9a4840f16edcd537e2914bbd6af448c
https://pubmed.ncbi.nlm.nih.gov/3398564
https://pubmed.ncbi.nlm.nih.gov/3398564
Publikováno v:
Lijecnicki vjesnik. 109(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9ce893836055a9d9337779595e8d65ed
https://pubmed.ncbi.nlm.nih.gov/3309515
https://pubmed.ncbi.nlm.nih.gov/3309515
Publikováno v:
Acta medica Iugoslavica. 40(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::496dead8e16fc00d2b01ad2d129b7f8e
https://pubmed.ncbi.nlm.nih.gov/3788662
https://pubmed.ncbi.nlm.nih.gov/3788662
Autor:
S, Eckhardt, J, Szántó, O, Cerar, V, Chylak, Z, Hernádi, I, Hindy, S, József, E, Juhos, K, Kolaric, J, Kopecny
Publikováno v:
Oncology. 44(2)
The therapeutic efficacy of the combination of cyclophosphamide + epirubicin + cisplatin was evaluated in 107 previously treated or untreated patients with advanced ovarian cancer. The overall response rate was 58.8%, complete remission 36.4% (mean d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7a6ebfb21cedb40aeafb4837a68ea016
https://pubmed.ncbi.nlm.nih.gov/3554083
https://pubmed.ncbi.nlm.nih.gov/3554083
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.